Hip Fractures (ICD-10 72.01-72.2)RECADONCT07478445
Home Rehabilitation After Hip Fracture
An observational study of Hip Fractures (ICD-10 72.01-72.2) and Home Care, Hospital-Based, run by Instituto de Investigacion Sanitaria La Fe at 1 site in Spain.
Trial summary
This study will examine whether a home-based rehabilitation program can help older adults recover after surgery for a hip fracture. The program is delivered by a specialized "Hospital-at-Home" unit, which provides hospital-level care in the patient's home. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Hip Fractures (ICD-10 72.01-72.2), Home Care, Hospital-Based, Home Care Services
- How many people
- 80 participants
- Where
- 1 siteSpain
- Study dates
- 1 Feb 2024to 30 Sep 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: Older undergoing surgery for traumatic hip fracture.
Who may be able to join
- - Patients aged 65 years or older undergoing surgery for traumatic hip fracture.
- Ability to actively collaborate in the physiotherapy program.
- Compliance with the UHD admission criteria (contact telephone number, identified caregiver, and residence within the geographical area of the Hospital Universitari i Politècnic La Fe).
Who cannot join
- - Patients residing outside the geographical area covered by the La Fe hospital UHD.
- Refusal to participate in the follow-up.
- Clinical instability or end-of-life situation (oncologic or non-oncologic).
- Cognitive impairment that prevents collaboration.
- Institutionalized patients.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: [Rehabilitación Domiciliaria Tras Fractura de Cadera] Home Rehabilitation After Hip Fracture
This study will examine whether a home-based rehabilitation program can help older adults recover after surgery for a hip fracture. The program is delivered by a specialized "Hospital-at-Home" unit, which provides hospital-level care in the patient's home.
Participants in this study are adults aged 65 years and older who have undergone hip fracture surgery at Hospital Universitari i Politècnic La Fe in Valencia, Spain. Instead of remaining in the hospital after surgery, participants will be admitted to the Hospital-at-Home program. A multidisciplinary medical team will provide comprehensive care at home, including medication management, wound care, and in-home physical therapy.
Read more
The primary goal of the study is to assess recovery of walking ability and mobility within the home. The study will also evaluate overall functional improvement, frailty, and survival. Participants will be assessed at the start of the program and again at 45 days and 180 days after surgery.
The information collected will help determine whether this type of home-based care is an effective option for supporting recovery and independence in older adults after a hip fracture.
Recruitment for the study began in February 2024 and is expected to continue for one year.
- Keywords
- Hospital at home, Multidisciplinary care, Patient Discharge, Physical Therapy Modalities, Functional Status, Adult, Aged, Hip Fractures, Home care services
- Medical subject headings
- Hip Fractures
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Home rehabilitation of hip fracture | The cohort included patients with hip fracture who were referred from the hospital to home-based rehabilitation at discharge, managed by a multidisciplinary team that included physiotherapists. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Walking ability and home transfers
Walking ability and home transfers, taken from the Barthel Index
Measured: assessed at different time points (prior, admission to the UHD, and at 45 and 180 days).
Secondary outcomes (5)
Functional improvement
measured by the change of the Barthel Index
Measured: prior, admission to the UHD, and at 45 and 180 days
Mortality
Number of deaths
Measured: 360 days
Frailty was assessed with the Rockwood Index at the time of admission, at baseline
The modified Clinical Frailty Scale (CFS) is a simple, 34-point clinical tool used by healthcare providers to quickly summarize a patient's overall level of fitness or frailty based on their mobility, energy, and function. It helps predict outcomes and guide care decisions in older adults.
Measured: Baseline
Number of participants with all-cause readmission, delirium, wound infection, or bleeding
Safety was assessed by monitoring the occurrence of all-cause readmissions, episodes of delirium, wound infection, or bleeding during the intervention period.
Measured: 15 days
Change in quality of life assessed by the EuroQoL-5D questionnaire
Quality of life was assessed using the EuroQol-5D-3L (EQ-5D-3L), a standardized instrument measuring health-related quality of life across five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each with three levels. The descriptive system defines health states and does not itself yield a single score with fixed minimum and maximum values. Health states can be converted into a utility index typically ranging from values below 0 (worse than death) to 1 (full health), where higher scores indicate better health. Changes in quality of life will be assessed at 12 months
Measured: One year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Mar 2026
- Study start1 Feb 2024
- Primary completion26 Feb 2025
- Study completion30 Sep 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hip Fractures (ICD-10 72.01-72.2)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 80 participants (actual)
Sponsor and investigators
- Lead sponsor
- Instituto de Investigacion Sanitaria La Fe
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Vicente Ruiz García, Instituto de Investigacion Sanitaria La Fe
- Investigators
- Ana Torrego, MD, PhD, Principal investigator, Hospital at Home Unit - Hospital UiP La Fe Valencia Avda Fernando Abril Martorell 106 Torre B Planta 1 Valencia 26206 (SPAIN)Ana Soler, MD, PhD, Study chair, Physical Medicine and Rehabilitation Service (SMFR); Hospital UiP La Fe Valencia Avda Fernando Abril Martorell 106Elisa Soriano, MD, PhD, Study chair, Hospital at Home Unit Hospital UiP La Fe Valencia Avda Fernando Abril Martorell 106 Torre B Planta 1 Valencia 26206 (SPAIN)Marta Muñoz Domingo, Senior Technician / Research C, Principal investigator, Universitat Politècnica de València (UPV) Centro de Investigación de Ingeniería Económica (CIEGS)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07478445
- Sponsor's protocol ID
- 2025-0224-1
- Acronym
- RECADO
- Status last verified
- Mar 2026
- First submitted
- 10 Mar 2026
- Last updated
- 19 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 19 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- [Rehabilitación Domiciliaria Tras Fractura de Cadera] Home Rehabilitation After Hip Fracture
- ClinicalTrials.gov ID
- NCT07478445
- Acronym / sponsor ID
- RECADO / 2025-0224-1
- Keywords
- Hospital at home, Multidisciplinary care, Patient Discharge, Physical Therapy Modalities, Functional Status, Adult, Aged, Hip Fractures
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 80 participants (actual)
- Lead sponsor
- Instituto de Investigacion Sanitaria La FeUniversity, hospital or other
- Study start
- 1 Feb 2024 (actual)
- Primary completion
- 26 Feb 2025 (actual)
- Study completion
- 30 Sep 2025 (actual)
- First posted
- 17 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will examine whether a home-based rehabilitation program can help older adults recover after surgery for a hip fracture. The program is delivered by a specialized "Hospital-at-Home" unit, which provides hospital-level care in the patient's home.
Participants in this study are adults aged 65 years and older who have undergone hip fracture surgery at Hospital Universitari i Politècnic La Fe in Valencia, Spain. Instead of remaining in the hospital after surgery, participants will be admitted to the Hospital-at-Home program. A multidisciplinary medical team will provide comprehensive care at home, including medication management, wound care, and in-home physical therapy.
The primary goal of the study is to assess recovery of walking ability and mobility within the home. The study will also evaluate overall functional improvement, frailty, and survival. Participants will be assessed at the start of the program and again at 45 days and 180 days after surgery.
The information collected will help determine whether this type of home-based care is an effective option for supporting recovery and independence in older adults after a hip fracture.
Recruitment for the study began in February 2024 and is expected to continue for one year.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Home rehabilitation of hip fracture | – | –The cohort included patients with hip fracture who were referred from the hospital to home-based rehabilitation at discharge, managed by a multidisciplinary team that included physiotherapists. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- Older undergoing surgery for traumatic hip fracture.
Key inclusion criteria (3 listed)
- - Patients aged 65 years or older undergoing surgery for traumatic hip fracture.
- Ability to actively collaborate in the physiotherapy program.
- Compliance with the UHD admission criteria (contact telephone number, identified caregiver, and residence within the geographical area of the Hospital Universitari i Politècnic La Fe).
Key exclusion criteria (5 listed)
- - Patients residing outside the geographical area covered by the La Fe hospital UHD.
- Refusal to participate in the follow-up.
- Clinical instability or end-of-life situation (oncologic or non-oncologic).
- Cognitive impairment that prevents collaboration.
- Institutionalized patients.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Walking ability and home transfers
Time frame: assessed at different time points (prior, admission to the UHD, and at 45 and 180 days).
Walking ability and home transfers, taken from the Barthel Index
5 secondary outcomes
Functional improvement
Time frame: prior, admission to the UHD, and at 45 and 180 days
Mortality
Time frame: 360 days
Frailty was assessed with the Rockwood Index at the time of admission, at baseline
Time frame: Baseline
Number of participants with all-cause readmission, delirium, wound infection, or bleeding
Time frame: 15 days
Change in quality of life assessed by the EuroQoL-5D questionnaire
Time frame: One year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Mar 2026.
- Individual participant dataSharing planned: Yes
Related trials for Hip Fractures (ICD-10 72.01-72.2)
Not yet recruitingPhase 4
Suzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip Fracture
Hip Fractures (ICD-10 72.01-72.2), Post Operative Analgesia
Not yet recruitingObservational study
Improving Shared DECISion-making in oldEr Hip Fracture Patients Living With Frailty
Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures), Hip Fractures (ICD-10 72.01-72.2)
RecruitingObservational study
Mobility and Activity of Daily Living Outcomes After a Hip Fracture.
Hip Fractures (ICD-10 72.01-72.2)
RecruitingObservational study
Population Pharmacokinetics and Pharmacodynamics of Ciprofol
Hip Fractures (ICD-10 72.01-72.2), Osteoarthritis, Knee and Hip
Recruiting
Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
Hip Fractures (ICD-10 72.01-72.2)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ana Torrego, MD, PhD principal investigator
Hospital at Home Unit - Hospital UiP La Fe Valencia Avda Fernando Abril Martorell 106 Torre B Planta 1 Valencia 26206 (SPAIN)
Ana Soler, MD, PhD study chair
Physical Medicine and Rehabilitation Service (SMFR); Hospital UiP La Fe Valencia Avda Fernando Abril Martorell 106
Elisa Soriano, MD, PhD study chair
Hospital at Home Unit Hospital UiP La Fe Valencia Avda Fernando Abril Martorell 106 Torre B Planta 1 Valencia 26206 (SPAIN)
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hip Fractures (ICD-10 72.01-72.2) and Home Care, Hospital-Based, run by Instituto de Investigacion Sanitaria La Fe at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Walking ability and home transfers (time frame: assessed at different time points (prior, admission to the UHD, and at 45 and 180 days).). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2026; AzTrials last refreshed its copy on 6 Nov 2026.